EDGAR Filing Documents for 0001096906-11-002277

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001096906-11-002277

Filing Date

2011-09-28

Accepted

2011-09-28 17:19:49

Documents

Period of Report

2011-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	AOXING PHARMACEUTICAL COMPANY, INC. FORM 10-K JUNE 30, 2011	axn10k20110630.htm	10-K	1154797
2	LIST OF SUBSIDIARIES	ex21-1.htm	EX-21.1	3603
3	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES	ex31-1.htm	EX-31.1	12217
4	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES	ex31-2.htm	EX-31.2	12170
5	CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350	ex32-1.htm	EX-32.1	6462
6	CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350	ex32-2.htm	EX-32.2	6462
	Complete submission text file	0001096906-11-002277.txt		1197052

Mailing Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302

Business Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302 646-367-1747

AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)